The institute seminar on Wednesday January 26th is given by Petras Juzenas from the Deparment of Radiation Biology.
Title of his talk: New drugs for therapy of cancer and neurodegenerative diseases
The seminar takes place in the Auditorium (New Research Building Montebello) and starts at 12:00.
New drugs for therapy of cancer and neurodegenerative diseases
Petras Juzenas from the Deparment of Radiation Biology
Nanoparticles have become of great interest for cancer research because of their properties that differ from bulk materials. So far most of the work has been focused on their imaging applications. The concept of using nanoparticles as radiosensitizers in cancer therapy has been recently proposed to enhance radiation effects. Novel proteasome and BCL-2 inhibitors that inhibit specific protein-protein interactions may also lead to significant therapeutic advances. In other non-cancer diseases nanoparticles have been found to prevent amyloidosis, a cause of Alzheimer's disease that cannot be cured. The main aim of the project group is to test in preclinical in vitro studies new drugs and select successful candidates that promise radical improvements in treating malignant cells and amyloid aggregates.